Semaglutide
Common brands: Ozempic, Wegovy, Metformin Hydrochloride, Metformin, Aspirin 325
Top reporter: Novo Nordisk Pharmaceutical Industries, Lp
GLP-1 Receptor Agonist [EPC]Insulin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Sodium-Glucose Cotransporter 2 Inhibitor [EPC]HMG-CoA Reductase Inhibitor [EPC]
76,509
Total Reports
66,856
Serious Reports
1,333
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.74%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Semaglutide.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | NAUSEA | 11,220 | |
| 2 | VOMITING | 7,403 | |
| 3 | OFF LABEL USE | 6,983 | |
| 4 | DIARRHOEA | 6,500 | |
| 5 | CONSTIPATION | 4,668 | |
| 6 | DECREASED APPETITE | 4,594 | |
| 7 | WEIGHT DECREASED | 4,038 | |
| 8 | FATIGUE | 3,486 | |
| 9 | HEADACHE | 3,294 | |
| 10 | PRODUCT USE IN UNAPPROVED INDICATION | 3,023 | |
| 11 | ABDOMINAL PAIN UPPER | 2,959 | |
| 12 | IMPAIRED GASTRIC EMPTYING | 2,950 | |
| 13 | BLOOD GLUCOSE INCREASED | 2,836 | |
| 14 | WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 2,830 | |
| 15 | DIZZINESS | 2,787 | |
| 16 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 2,654 | |
| 17 | WEIGHT INCREASED | 2,541 | |
| 18 | ABDOMINAL PAIN | 2,496 | |
| 19 | DEHYDRATION | 2,114 | |
| 20 | MALAISE | 1,984 | |
| 21 | DRUG INEFFECTIVE | 1,956 | |
| 22 | ASTHENIA | 1,954 | |
| 23 | PAIN | 1,827 | |
| 24 | ILLNESS | 1,781 | |
| 25 | DYSPEPSIA | 1,680 | |
| 26 | ABDOMINAL DISTENSION | 1,652 | |
| 27 | DYSPNOEA | 1,574 | |
| 28 | ABDOMINAL DISCOMFORT | 1,496 | |
| 29 | ANXIETY | 1,478 | |
| 30 | ARTHRALGIA | 1,435 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.